CRIS Current Research Information System

Tibaldi C, Giovannetti E, Tiseo M, Danesi R, Leon LG, Bartolotti M, et al. (2009). Correlation between cytidine deaminase (CDA) genotype and clinical outcome/toxicity in advanced non-small cell lung cancer (NSCLC) patients treated with gemcitabine/platinum-based chemotherapy. JOURNAL OF THORACIC ONCOLOGY, 4(9), S553-S553.

Correlation between cytidine deaminase (CDA) genotype and clinical outcome/toxicity in advanced non-small cell lung cancer (NSCLC) patients treated with gemcitabine/platinum-based chemotherapy

ARDIZZONI, ANDREA
2009
2009
Tibaldi C, Giovannetti E, Tiseo M, Danesi R, Leon LG, Bartolotti M, et al. (2009). Correlation between cytidine deaminase (CDA) genotype and clinical outcome/toxicity in advanced non-small cell lung cancer (NSCLC) patients treated with gemcitabine/platinum-based chemotherapy. JOURNAL OF THORACIC ONCOLOGY, 4(9), S553-S553.
Tibaldi C; Giovannetti E; Tiseo M; Danesi R; Leon LG; Bartolotti M; D'Incecco A; Erozenci AL; Falcone A; Peters GJ; Ardizzoni A
1.06 Abstract in rivista
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/595257
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact